Town & Country Bank & Trust CO dba First Bankers Trust CO cut its stake in Xylem Inc (NYSE:XYL) by 5.7% in the 3rd quarter, HoldingsChannel reports. The fund owned 15,201 shares of the industrial products company’s stock after selling 925 shares during the period. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Xylem were worth $1,210,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Buffington Mohr McNeal lifted its position in Xylem by 7.9% in the 3rd quarter. Buffington Mohr McNeal now owns 57,031 shares of the industrial products company’s stock worth $4,541,000 after buying an additional 4,177 shares in the last quarter. Pacer Advisors Inc. grew its stake in Xylem by 10.8% in the 3rd quarter. Pacer Advisors Inc. now owns 18,982 shares of the industrial products company’s stock valued at $1,511,000 after buying an additional 1,855 shares during the last quarter. Baldwin Brothers Inc. MA grew its stake in Xylem by 24.2% in the 3rd quarter. Baldwin Brothers Inc. MA now owns 70,661 shares of the industrial products company’s stock valued at $5,626,000 after buying an additional 13,758 shares during the last quarter. We Are One Seven LLC grew its stake in Xylem by 2.7% in the 3rd quarter. We Are One Seven LLC now owns 7,150 shares of the industrial products company’s stock valued at $569,000 after buying an additional 185 shares during the last quarter. Finally, Douglass Winthrop Advisors LLC grew its stake in Xylem by 13.3% in the 3rd quarter. Douglass Winthrop Advisors LLC now owns 5,344 shares of the industrial products company’s stock valued at $425,000 after buying an additional 627 shares during the last quarter. Institutional investors and hedge funds own 84.49% of the company’s stock.
A number of research firms recently issued reports on XYL. ValuEngine lowered shares of Xylem from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Jefferies Financial Group began coverage on shares of Xylem in a research note on Friday, September 20th. They issued a “buy” rating and a $90.00 target price on the stock. Zacks Investment Research upgraded shares of Xylem from a “sell” rating to a “hold” rating and set a $83.00 target price on the stock in a research note on Saturday, September 14th. Finally, Credit Suisse Group lowered shares of Xylem from an “outperform” rating to a “neutral” rating in a research note on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $80.00.
In other Xylem news, SVP Kenneth Napolitano sold 5,000 shares of the firm’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $77.49, for a total value of $387,450.00. Following the sale, the senior vice president now directly owns 46,228 shares in the company, valued at approximately $3,582,207.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Colin R. Sabol sold 4,099 shares of the firm’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $78.37, for a total transaction of $321,238.63. Following the completion of the sale, the senior vice president now owns 33,518 shares in the company, valued at $2,626,805.66. The disclosure for this sale can be found here. Insiders sold a total of 19,099 shares of company stock worth $1,464,339 over the last 90 days. Company insiders own 0.85% of the company’s stock.
NYSE XYL traded up $3.03 during midday trading on Friday, hitting $78.46. The company had a trading volume of 17,796 shares, compared to its average volume of 782,832. The company has a quick ratio of 1.08, a current ratio of 1.47 and a debt-to-equity ratio of 0.71. The stock has a market cap of $13.22 billion, a price-to-earnings ratio of 27.27, a P/E/G ratio of 1.41 and a beta of 1.19. The firm has a fifty day simple moving average of $76.89 and a two-hundred day simple moving average of $78.95. Xylem Inc has a fifty-two week low of $60.65 and a fifty-two week high of $85.39.
Xylem (NYSE:XYL) last posted its quarterly earnings results on Thursday, August 1st. The industrial products company reported $0.79 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.79. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.35 billion. Xylem had a net margin of 10.90% and a return on equity of 19.23%. The business’s quarterly revenue was up 2.1% on a year-over-year basis. During the same period last year, the business posted $0.73 EPS. As a group, equities analysts predict that Xylem Inc will post 3.16 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th were given a $0.24 dividend. The ex-dividend date was Wednesday, August 28th. This represents a $0.96 annualized dividend and a yield of 1.22%. Xylem’s dividend payout ratio is 33.33%.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Featured Article: Asset Allocation Models, Which is Right For You?
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.